{"id":274909,"date":"2026-09-28T13:23:40","date_gmt":"2026-09-28T07:53:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=274909"},"modified":"2026-09-28T13:23:40","modified_gmt":"2026-09-28T07:53:40","slug":"why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/","title":{"rendered":"Aspira Pathlab &#038; Diagnostics Ltd. (ASPIRA): Aspira Pathlab &#038; Diagnostics Share Price rises 4.98% near 52-week high"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) share price is trading within 2% of its 52-week high today and stood at Rs 136.5, up 4.98% from the previous close. Market cap was Rs 133.83 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><strong>Aspira Pathlab &#038; Diagnostics Share Price<\/strong> is trading at Rs 136.5, up 4.98% today, and remains close to its 52-week high while the company\u2019s market capitalisation stands at Rs 133.83 crore.<\/p>\n<p style=\"margin-top:0!important;\"><strong>Aspira Pathlab &#038; Diagnostics Share Price<\/strong> is in focus after the stock traded at Rs 136.5 on 28 September 2026 at 1:22 PM IST, up Rs 6.48 from the previous close of Rs 130.02. The move has kept Aspira Pathlab &#038; Diagnostics Share Price close to its 52-week high and has placed the name in current market watchlists, while its market capitalisation remains Rs 133.83 crore. The latest Univest data confirms the price event, but it does not establish any company-specific catalyst. For readers tracking Aspira Pathlab &#038; Diagnostics Share Price Today, the key takeaway is that the stock is holding near a yearly high after an intraday move that took it to Rs 136.5.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Aspira_Pathlab_Diagnostics_Share_Price_Today_Price_Action_Analysis\" title=\"Aspira Pathlab &#038; Diagnostics Share Price Today: Price Action Analysis\">Aspira Pathlab &#038; Diagnostics Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Aspira_Pathlab_Diagnostics_Ltd_ASPIRA_Fundamental_Analysis\" title=\"Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) Fundamental Analysis\">Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Why_Investors_Are_Watching_Aspira_Pathlab_Diagnostics\" title=\"Why Investors Are Watching Aspira Pathlab &#038; Diagnostics\">Why Investors Are Watching Aspira Pathlab &#038; Diagnostics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#About_Aspira_Pathlab_Diagnostics\" title=\"About Aspira Pathlab &#038; Diagnostics\">About Aspira Pathlab &#038; Diagnostics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Why_is_Aspira_Pathlab_Diagnostics_Share_Price_in_focus_today\" title=\"Why is Aspira Pathlab &amp; Diagnostics Share Price in focus today?\">Why is Aspira Pathlab &amp; Diagnostics Share Price in focus today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#What_is_the_current_Aspira_Pathlab_Diagnostics_Share_Price\" title=\"What is the current Aspira Pathlab &amp; Diagnostics Share Price?\">What is the current Aspira Pathlab &amp; Diagnostics Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#How_much_did_Aspira_Pathlab_Diagnostics_Share_Price_move_today\" title=\"How much did Aspira Pathlab &amp; Diagnostics Share Price move today?\">How much did Aspira Pathlab &amp; Diagnostics Share Price move today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Is_Aspira_Pathlab_Diagnostics_Share_Price_near_a_52-week_high\" title=\"Is Aspira Pathlab &amp; Diagnostics Share Price near a 52-week high?\">Is Aspira Pathlab &amp; Diagnostics Share Price near a 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#What_is_the_market_capitalisation_of_Aspira_Pathlab_Diagnostics\" title=\"What is the market capitalisation of Aspira Pathlab &amp; Diagnostics?\">What is the market capitalisation of Aspira Pathlab &amp; Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#How_do_the_valuation_metrics_look_for_Aspira_Pathlab_Diagnostics_Share_Price\" title=\"How do the valuation metrics look for Aspira Pathlab &amp; Diagnostics Share Price?\">How do the valuation metrics look for Aspira Pathlab &amp; Diagnostics Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#What_do_ROE_and_ROCE_say_about_Aspira_Pathlab_Diagnostics\" title=\"What do ROE and ROCE say about Aspira Pathlab &amp; Diagnostics?\">What do ROE and ROCE say about Aspira Pathlab &amp; Diagnostics?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#How_does_Aspira_Pathlab_Diagnostics_compare_with_peers\" title=\"How does Aspira Pathlab &amp; Diagnostics compare with peers?\">How does Aspira Pathlab &amp; Diagnostics compare with peers?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-aspira-pathlab-and-diagnostics-ltd-share-price-near-52-week-high-today-2026\/#Track_Aspira_Pathlab_Diagnostics_Share_Price_on_Univest\" title=\"Track Aspira Pathlab &#038; Diagnostics Share Price on Univest\">Track Aspira Pathlab &#038; Diagnostics Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Aspira_Pathlab_Diagnostics_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Aspira Pathlab &#038; Diagnostics Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The latest Aspira Pathlab &#038; Diagnostics Share Price update also shows that the stock opened at Rs 136 and touched a day high of Rs 136.5, while the day low was Rs 124.01. That range gives a clear picture of the day\u2019s price action without adding any unsupported explanation. Aspira Pathlab &#038; Diagnostics Stock News therefore centres on the observed move itself, along with valuation and healthcare-sector context discussed later in this article.<\/p>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 136.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 130.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 6.48 (+4.98%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 136<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 136.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 124.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 133.83 crore<\/td>\n<\/tr>\n<\/table>\n<p>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) traded at Rs 136.5 versus the previous close of Rs 130.02, a rise of 4.98%. The stock opened at Rs 136, reached a high of Rs 136.5 and touched a low of Rs 124.01.<\/p>\n<p><strong>Aspira Pathlab &#038; Diagnostics Share Price Today<\/strong> shows a day move of Rs 6.48, or 4.98%, against the previous close of Rs 130.02. The stock is trading at Rs 136.5, the same as the day high, after opening at Rs 136 and marking a low of Rs 124.01. That places Aspira Pathlab &#038; Diagnostics Share Price close to its 52-week high and within a narrow band near the upper end of the day\u2019s range. For readers following Aspira Pathlab &#038; Diagnostics Share Price Live, the latest print confirms that the near-yearly-high event is being reflected directly in the price.<\/p>\n<p>Aspira Pathlab &#038; Diagnostics Share Price News remains relevant because the stock is holding above the previous close by a visible margin, while the market capitalisation is still Rs 133.83 crore. The move is a factual price event and not a stated catalyst story. The current setup makes Aspira Pathlab &#038; Diagnostics Share Price a stock worth tracking alongside the broader stock market today and share market today screen for 52 week high stocks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Aspira_Pathlab_Diagnostics_Ltd_ASPIRA_Fundamental_Analysis\"><\/span><strong>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 133.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.59x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.13%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.33<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 12.28<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) fundamental metrics show P\/E 55.79x, P\/B 10.59x, ROE 18.13%, ROCE 19.27%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Aspira Pathlab &#038; Diagnostics Ltd. has a market capitalisation of Rs 133.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 55.79x, P\/B at 10.59x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.13% and ROCE of 19.27%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.33, book value per share of Rs 12.28, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 44.07x, median ROE of 12.77%, median ROCE of 15.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Hospital &amp; Healthcare Services<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">44.07x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">90.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,602.7x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.59x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.13%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.77%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">19.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">15.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 133.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 544.65 crore<\/td>\n<\/tr>\n<\/table>\n<p>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) is classified under sector: Healthcare and industry: Hospital &amp; Healthcare Services.<\/p>\n<p>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) has a P\/E ratio of 55.79x, which is above the benchmark median of 44.07x, a difference of +26.59%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) has a ROE of 18.13%, which is above the benchmark median of 12.77%, a difference of +41.97%. Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) has a ROCE of 19.27%, which is above the benchmark median of 15.61%, a difference of +23.45%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/starimagin\/star-imaging-and-path-lab-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Star Imaging and Path Lab Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">STARIMAGIN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">135.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.81<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nephrocare\/nephro-care-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Nephro Care India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NEPHROCARE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">154.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">45.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.42<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/mdrc\/modern-diagnostic-and-research-c-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>MODERN DIAGNOSTIC &amp; RESEARCH C<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MDRC<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">114.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/madhavbaug\/vaidya-sane-ayurved-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Vaidya Sane Ayurved Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">MADHAVBAUG<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">169.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.86<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/invicta\/invicta-diagnostic-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Invicta Diagnostic Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INVICTA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.85<\/td>\n<\/tr>\n<\/table>\n<p>Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) has a P\/E ratio of 55.79x compared with the displayed peer median of 18.86x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.13% compares with a peer median of 40.48% across the companies shown in the table. ROCE stood at 19.27% versus the displayed peer median of 33.81%, providing a capital-efficiency comparison. Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) has a market capitalisation of Rs 133.83 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Aspira_Pathlab_Diagnostics\"><\/span><strong>Why Investors Are Watching Aspira Pathlab &#038; Diagnostics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Aspira Pathlab &#038; Diagnostics Share Price is trading at Rs 136.5, up 4.98% from the previous close.<\/li>\n<li>The stock is near its 52-week high and one-year high on the latest trade.<\/li>\n<li>P\/E is 55.79 and P\/B is 10.59, both above the same-industry medians.<\/li>\n<li>ROE is 18.13% and ROCE is 19.27%, both above the benchmark medians.<\/li>\n<li>Market capitalisation stands at Rs 133.83 crore, which helps place Aspira Pathlab &#038; Diagnostics Share Price in context within the healthcare universe.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Aspira_Pathlab_Diagnostics\"><\/span><strong>About Aspira Pathlab &#038; Diagnostics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Aspira Pathlab &#038; Diagnostics Share Price<\/strong> belongs to Aspira Pathlab &#038; Diagnostics Ltd., which operates in the Healthcare sector and the Hospital &amp; Healthcare Services industry. The company\u2019s market data places it within a broad listed peer group that includes diagnostics and hospital-focused names. Aspira Pathlab &#038; Diagnostics Stock News is therefore read through both company-specific metrics and the wider healthcare benchmark set. For readers tracking Aspira Pathlab &#038; Diagnostics Share Price Today, this company profile provides the sector and industry context used in valuation comparisons.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Aspira_Pathlab_Diagnostics_Share_Price_in_focus_today\"><\/span><strong>Why is Aspira Pathlab &amp; Diagnostics Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aspira Pathlab &amp; Diagnostics Share Price is in focus because it is trading at Rs 136.5, up 4.98% from the previous close, and remains close to its 52-week high during the current market session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_Aspira_Pathlab_Diagnostics_Share_Price\"><\/span><strong>What is the current Aspira Pathlab &amp; Diagnostics Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aspira Pathlab &amp; Diagnostics Share Price is Rs 136.5 as of 28 September 2026 at 1:22 PM IST. The stock is above the previous close of Rs 130.02 and is trading near its yearly high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Aspira_Pathlab_Diagnostics_Share_Price_move_today\"><\/span><strong>How much did Aspira Pathlab &amp; Diagnostics Share Price move today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aspira Pathlab &amp; Diagnostics Share Price moved up by Rs 6.48, or 4.98%, compared with the previous close. The day high is Rs 136.5 and the day low is Rs 124.01, showing the day\u2019s range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Aspira_Pathlab_Diagnostics_Share_Price_near_a_52-week_high\"><\/span><strong>Is Aspira Pathlab &amp; Diagnostics Share Price near a 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, Aspira Pathlab &amp; Diagnostics Share Price is trading near its 52-week high. The latest trade at Rs 136.5 places the stock close to its yearly peak on the current market reading.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Aspira_Pathlab_Diagnostics\"><\/span><strong>What is the market capitalisation of Aspira Pathlab &amp; Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aspira Pathlab &amp; Diagnostics has a market capitalisation of Rs 133.83 crore. That figure helps position Aspira Pathlab &amp; Diagnostics Share Price within the healthcare listed-company universe and benchmark comparisons.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_the_valuation_metrics_look_for_Aspira_Pathlab_Diagnostics_Share_Price\"><\/span><strong>How do the valuation metrics look for Aspira Pathlab &amp; Diagnostics Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Aspira Pathlab &amp; Diagnostics Share Price is associated with a P\/E ratio of 55.79 and a P\/B ratio of 10.59. Both are above the same-industry medians shown in the healthcare benchmark set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_ROE_and_ROCE_say_about_Aspira_Pathlab_Diagnostics\"><\/span><strong>What do ROE and ROCE say about Aspira Pathlab &amp; Diagnostics?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE is 18.13% and ROCE is 19.27% for Aspira Pathlab &amp; Diagnostics. Both sit above the same-industry medians, which gives Aspira Pathlab &amp; Diagnostics Share Price additional financial context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Aspira_Pathlab_Diagnostics_compare_with_peers\"><\/span><strong>How does Aspira Pathlab &amp; Diagnostics compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In peer comparison, Aspira Pathlab &amp; Diagnostics Share Price has a higher P\/E than several listed peers, while ROE and ROCE sit above some peers and below others. The comparison is mixed and should be read with valuation context.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Aspira Pathlab & Diagnostics Share Price in focus today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aspira Pathlab & Diagnostics Share Price is in focus because it is trading at Rs 136.5, up 4.98% from the previous close, and remains close to its 52-week high during the current market session.\"}},{\"@type\":\"Question\",\"name\":\"What is the current Aspira Pathlab & Diagnostics Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aspira Pathlab & Diagnostics Share Price is Rs 136.5 as of 28 September 2026 at 1:22 PM IST. The stock is above the previous close of Rs 130.02 and is trading near its yearly high.\"}},{\"@type\":\"Question\",\"name\":\"How much did Aspira Pathlab & Diagnostics Share Price move today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aspira Pathlab & Diagnostics Share Price moved up by Rs 6.48, or 4.98%, compared with the previous close. The day high is Rs 136.5 and the day low is Rs 124.01, showing the day\u2019s range.\"}},{\"@type\":\"Question\",\"name\":\"Is Aspira Pathlab & Diagnostics Share Price near a 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, Aspira Pathlab & Diagnostics Share Price is trading near its 52-week high. The latest trade at Rs 136.5 places the stock close to its yearly peak on the current market reading.\"}},{\"@type\":\"Question\",\"name\":\"What is the market capitalisation of Aspira Pathlab & Diagnostics?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aspira Pathlab & Diagnostics has a market capitalisation of Rs 133.83 crore. That figure helps position Aspira Pathlab & Diagnostics Share Price within the healthcare listed-company universe and benchmark comparisons.\"}},{\"@type\":\"Question\",\"name\":\"How do the valuation metrics look for Aspira Pathlab & Diagnostics Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Aspira Pathlab & Diagnostics Share Price is associated with a P\/E ratio of 55.79 and a P\/B ratio of 10.59. Both are above the same-industry medians shown in the healthcare benchmark set.\"}},{\"@type\":\"Question\",\"name\":\"What do ROE and ROCE say about Aspira Pathlab & Diagnostics?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ROE is 18.13% and ROCE is 19.27% for Aspira Pathlab & Diagnostics. Both sit above the same-industry medians, which gives Aspira Pathlab & Diagnostics Share Price additional financial context.\"}},{\"@type\":\"Question\",\"name\":\"How does Aspira Pathlab & Diagnostics compare with peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"In peer comparison, Aspira Pathlab & Diagnostics Share Price has a higher P\/E than several listed peers, while ROE and ROCE sit above some peers and below others. The comparison is mixed and should be read with valuation context.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Aspira_Pathlab_Diagnostics_Share_Price_on_Univest\"><\/span><strong>Track Aspira Pathlab &#038; Diagnostics Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/aspira\/aspira-pathlab-and-diagnostics-ltd-share-price-today\">Aspira Pathlab &amp; Diagnostics Ltd. (ASPIRA) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aspira Pathlab &#038; Diagnostics Ltd. Share Price trades near its 52-week high at Rs 136.5, marking a 4.98% rise today. Market cap stands at Rs 133.83 crore.<\/p>\n","protected":false},"author":38,"featured_media":274905,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-274909","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["274905"],"rank_math_title":["Aspira Pathlab &amp; Diagnostics Share Price near 52-week high"],"rank_math_description":["Aspira Pathlab &amp; Diagnostics Share Price is near its 52-week high after a 4.98% move. See price action, valuation, and sector context."],"rank_math_focus_keyword":["Aspira Pathlab & Diagnostics Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/aspira-pathlab-and-diagnostics-ltd-aspira-aspira-pathlab-and-diagnostics-share.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/274909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=274909"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/274909\/revisions"}],"predecessor-version":[{"id":274910,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/274909\/revisions\/274910"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/274905"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=274909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=274909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=274909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}